Status:
COMPLETED
On the Cyberknife Dose Fraction of Liver Cancer Treatment
Lead Sponsor:
Beijing 302 Hospital
Conditions:
CyberKnife Radiosurgery
Eligibility:
All Genders
30-80 years
Brief Summary
The research aims to the primary hepatic carcinoma patients whose diameter of the single tumor is equal or less than 5cm.By supervising the changes of liver function, Child-Pugh score, ICG-R15 value, ...
Eligibility Criteria
Inclusion
- The participants are from 30 to 80 years of age, without gender restriction
- With the hepatopathy background, the diagnosis of primary hepatic carcinoma is confirmed by image examination and laboratory test(the diagnosis criteria is according to the primary hepatic carcinoma rule of diagnosis and treat in 2007)
- The max diameter of single tumor ≤5cm
- Child-Pugh Classification(CPC) A or B
- ECOG score 0 or 1
- Leukocyte is more than 2×109/L and thrombocyte is more than 60×109/L
- Kidney function is normal
- Unsuitable or rejecting other therapies such as resection, liver transplantation etc
- Anticipated lifetime is longer than six months
- The participants who are voluntary comply with the requirements of research
- The participants agree to sign the informed consent.
Exclusion
- The metastasis occur outside of liver
- Child-Pugh Classification(CPC)
- The outline of tumor is not confirmed by image examination
- With hepatic or any other abdomen radiotherapy history before
- With severe internal medicine diseases
- Bone marrow haematopoietic function or kidney function is severe failure
- Intractable ascites
- The position of tumor is nearby esophagus, stomach or intestine
- The normal liver volume less than 700 cm3
Key Trial Info
Start Date :
November 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 24 2021
Estimated Enrollment :
657 Patients enrolled
Trial Details
Trial ID
NCT03295500
Start Date
November 1 2017
End Date
September 24 2021
Last Update
October 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CyberKnife
Beijing, Beijing Municipality, China, 100039